Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide

scientific article published in March 2011

Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3899/JRHEUM.101143
P698PubMed publication ID21362765
P5875ResearchGate publication ID50249759

P2093author name stringAmal M El-Barbary
Elham M Kassem
Mervat A S El-Sergany
Mohamed A Eltomey
Salwa A-M Essa
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
atherosclerosisQ12252367
P304page(s)828-834
P577publication date2011-03-01
P1433published inThe Journal of RheumatologyQ7743623
P1476titleAssociation of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide
P478volume38

Reverse relations

cites work (P2860)
Q51273023Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Q35994186Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.
Q40556385Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid Arthritis
Q46114885Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis
Q36253671Atherosclerosis and rheumatoid arthritis: more than a simple association
Q38185646Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?
Q34081242Cardiovascular involvement in autoimmune diseases
Q33849849Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generatio
Q35674804Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: A meta-analysis
Q49160612Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association
Q35854740Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis
Q37000208Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis
Q36932166Is preclinical autoimmunity benign?: The case of cardiovascular disease
Q34343906Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus
Q92003375NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology
Q38098935Novel risk factors for cardiovascular disease in rheumatoid arthritis
Q58051983Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis
Q53827279Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age.
Q35954706Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality

Search more.